Cosentyx (secukinumab) is a prescription drug used to treat certain types of arthritis and other conditions. The drug comes as a liquid solution inside single-use pens, syringes, and vials. It may be ...

It’s also available as a liquid solution in a single-dose vial to administer as an intravenous (IV) infusion. Only a healthcare professional can administer this form. Your healthcare professional can ...

Cosentyx (secukinumab) is a prescription drug used to treat multiple conditions, including plaque psoriasis in adults and children ages 6 years and older. Cosentyx is not available as a generic or ...

The Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) injections for treating various inflammatory conditions in adults and, in some cases, children. Cosentyx may treat moderate ...

Credit: Novartis The IV formulation is supplied as a 125mg/5mL solution in a single-dose vial and requires dilution prior to administration. The Food and Drug Administration (FDA) has approved an ...

The Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) injections to treat several inflammatory conditions. Adults and certain children can receive this medication to treat ...

What Is Cosentyx, and Why Does It Matter? Cosentyx (secukinumab) is a fully human biologic medicine that targets and blocks interleukin‑17A (IL‑17A), a naturally occurring protein in the body that ...

Cosentyx, an autoimmune disease therapy that cost the healthcare industry $7.7 billion in 2024, will be offered at a 55% discount beginning in November. The drug’s manufacturer, Novartis, said Sept.